Results 31 to 40 of about 1,121 (144)

Reply to: “External validation of aMAP risk score in patients with chronic hepatitis C genotype 4 and cirrhosis who achieved SVR following DAAs” [PDF]

Journal of Hepatology, 2021
Rong Fan, Xueru Yin, Jinlin Hou
exaly   +3 more sources

Validation of Risk Models for Predicting Post-SVR HCC in Real-World Surveillance Across Global Geographic Regions. [PDF]

Liver Int
ABSTRACT Background & Aims Several clinical risk models have been proposed to stratify hepatocellular carcinoma (HCC) risk in patients with chronic hepatitis C virus (HCV) after sustained virologic response (SVR). However, validation efforts have focused on monocentric or country‐specific cohorts, and it is unclear if clinical risk models can be ...
Toyoda H, Hoshida Y, Parikh ND, Jalal PK, Piñero F, Mendizabal M, Ridruejo E, Cheinquer H, Casadei-Gardini A, Kanneganti M, Weinmann A, Peck-Radosavljevic M, Dufour JF, Radu P, Shiha G, Soliman R, Sarin SK, Kumar M, Wang JH, Tangkijvanich P, Sukeepaisarnjaroen W, Atsukawa M, Uojima H, Nozaki A, Nakamuta M, Takaguchi K, Hiraoka A, Abe H, Matsuura K, Watanabe T, Shimada N, Tsuji K, Ishikawa T, Mikami S, Itobayashi E, Johnson PJ, Singal AG.   +36 more
europepmc   +2 more sources

Validation of Noninvasive Markers for HCC Risk Stratification in 1389 Patients With Biopsy-proven NAFLD

Gastro Hep Advances, 2023
Background and Aims: Nonalcoholic fatty liver diseases (NAFLD) and nonalcoholic steatohepatitis (NASH) can cause hepatocellular carcinoma (HCC). We examined histological features and reported noninvasive markers/models for stratifying the risk of HCC ...
Hidenori Toyoda, Hideki Fujii, Michihiro Iwaki, Hideki Hayashi, Satoshi Oeda, Hideyuki Hyogo, Miwa Kawanaka, Asahiro Morishita, Kensuke Munekage, Kazuhito Kawata, Sakura Yamamura, Koji Sawada, Tatsuji Maeshiro, Hiroshi Tobita, Yuichi Yoshida, Masafumi Naito, Asuka Araki, Shingo Arakaki, Takumi Kawaguchi, Hidenao Noritake, Masafumi Ono, Tsutomu Masaki, Satoshi Yasuda, Eiichi Tomita, Masato Yoneda, Norifumi Kawada, Akihiro Tokushige, Yoshihiro Kamada, Hirokazu Takahashi, Shinichiro Ueda, Shinichi Aishima, Yoshio Sumida, Atsushi Nakajima, Takeshi Okanoue   +33 more
doaj   +1 more source

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria

Oncology, 2023
Introduction: The aMAP score is a prediction model for hepatocellular carcinoma (HCC) risk in chronic hepatitis patients. This study was conducted to elucidate the utility of this model for predicting initial recurrence of HCC in patients within the Milan criteria after undergoing curative treatment.
Ohama, Hideko, Hiraoka, Atsushi, Tada, Fujimasa, Kato, Kanako, Fukunishi, Yoshiko, Yanagihara, Emi, Kato, Masaya, Saneto, Hironobu, Izumoto, Hirofumi, Ueki, Hidetaro, Yoshino, Takeaki, Kitahata, Shogo, Kawamura, Tomoe, Kuroda, Taira, Suga, Yoshifumi, Miyata, Hideki, Hirooka, Masashi, Abe, Masanori, Matsuura, Bunzo, Ninomiya, Tomoyuki, Hiasa, Yoichi   +20 more
openaire   +2 more sources

Current and new strategies for hepatocellular carcinoma surveillance. [PDF]

Gastroenterol Rep (Oxf)
Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality worldwide, particularly among individuals with chronic liver diseases.
Polpichai N, Maneenil C, Danpanichkul P, Rattananukrom C, Choudhury A, Wong YJ, Sripongpun P, Liangpunsakul S, Kaewdech A.   +8 more
europepmc   +2 more sources

GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study [PDF]

, 2023
Background and aims: Surveillance programs are strongly recommended in patients with liver cirrhosis for early detection of HCC development. Six-monthly ultrasound sonography is the most reliable and commonly used technique, especially when associated ...
Semellini, Filippo, Tedesco, Calogero C, Ascari, Sara, Donghia, Rossella, Shahini, Endrit, Villa, Erica, Baldaccini, Valentina, Schepis, Filippo, Coletta, Sergio, Cozzolongo, Raffaele, Giannelli, Gianluigi, Lasagni, Simone, Pesole, Pasqua Letizia, Critelli, Rosina Maria   +13 more
core   +1 more source

Long-Term Hepatocellular Carcinoma Development and Predictive Ability of Non-Invasive Scoring Systems in Patients with HCV-Related Cirrhosis Treated with Direct-Acting Antivirals [PDF]

, 2022
Patients with hepatitis C virus (HCV)-related cirrhosis treated with direct-acting antivirals (DAA) are still at risk of developing hepatocellular carcinoma (HCC).
Alessia Ciancio, Giulia Troshina, Francesco Bombaci, Saracco, G. M., Umberto Santaniello, Santaniello, U., Nicolosi, A., Giulia Rosati, Troshina, G., Caviglia, G. P., Gian Paolo Caviglia, Giovanni Birolo, Aurora Nicolosi, Birolo, G., Ciancio, A., Giorgio Maria Saracco   +15 more
core   +1 more source

Non-Achievement of Alanine Aminotransferase Normalization Associated with the Risk of Hepatocellular Carcinoma during Nucleos(t)ide Analogue Therapies: A Multicenter Retrospective Study

, 2022
Patients with a chronic hepatitis B virus (HBV) infection who are treated with nucleos(t)ide analogues (NAs) are still at risk for hepatocellular carcinoma (HCC), and it has been clinically questioned whether patients with a high risk of HCC can be ...
THERME Study Group THERME Study Group, Kobayashi, Tomoo, Nagasaki, Futoshi, Niitsuma, Hirofumi, Takai, Satoshi, Tomoaki Iwata, Akahane, Takehiro, Hirofumi Niitsuma, Iwata, Tomoaki, Masashi Ninomiya, Atsushi Masamune, Sano, Akitoshi, Norihiro Kisara, Masahito Miura, Inoue, Jun, Toshihiro Sato, Miura, Masahito, Masazumi Onuki, Sato, Kosuke, Masamune, Atsushi, Onuki, Masazumi, Satoshi Takai, Kimura, Osamu, Kisara, Norihiro, Nakamura, Takuya, Futoshi Nagasaki, Mio Tsuruoka, Takuya Nakamura, Umetsu, Teruyuki, Jun Inoue, Teruyuki Umetsu, Ninomiya, Masashi, Kosuke Sato, Tsuruoka, Mio, Sato, Toshihiro, Takehiro Akahane, Tomoo Kobayashi, Osamu Kimura, Akitoshi Sano   +38 more
core   +1 more source

Hepatocellular carcinoma risk scores predict patients under surveillance at low risk of benefit and high risk of harm

, 2023
Surveillance for hepatocellular carcinoma (HCC) is recommended for patients with cirrhosis. Multiple risk scores aim to stratify HCC risk, potentially allowing individualized surveillance strategies.
Curran, Chris, Datta, Shouren, Priest, Matthew, Barclay, Stephen T., Forrest, Ewan H., Stanley, Adrian J.   +5 more
core   +1 more source

Enhancing Hepatocellular Carcinoma Surveillance: Comparative Evaluation of AFP, AFP-L3, DCP and Composite Models in a Biobank-Based Case-Control Study. [PDF]

Cancers (Basel)
Background/Objectives: Biomarkers such as lens agglutinin-reactive alpha-fetoprotein and des-gamma-carboxy prothrombin, as well as biomarker- and/or clinical-parameter-derived composite models (GALAD, GAAP, ASAP, aMAP, Doylestown), may improve detection ...
Demirtas CO, Akin S, Yilmaz Karadag D, Yilmaz T, Ciftci U, Huseynov J, Tolu Bulte T, Armutcuoglu Kaldirim Y, Dilber F, Ozdogan OC, Eren F.   +10 more
europepmc   +2 more sources